908 Devices Inc. reports results for the quarter ended in January - Earnings Summary
30/04/2024 16:21
* 908 Devices Inc. MASS.OQ reported a quarterly adjusted
loss
of 33 cents per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -39 cents. The mean expectation of five analysts for the
quarter was for a loss of 36 cents per share. Wall Street
expected results to range from -41 cents to -33 cents per share.
* Revenue rose 5.3% to $9.99 million from a year ago;
analysts
expected $9.29 million.
* 908 Devices Inc.'s reported EPS for the quarter was a loss
of 33
cents.
* The company reported a quarterly loss of $10.92 million.
* 908 Devices Inc. shares had fallen by 23.8% this
quarter and
lost 48.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "strong buy"
Wall Street's median 12-month price target for 908 Devices Inc.
is $15.00
This summary was machine generated from LSEG data April 30 at
03:21 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.36 -0.33 Beat
Dec. 31 2023 -0.26 -0.23 Beat
Sep. 30 2023 -0.30 -0.22 Beat
Jun. 30 2023 -0.35 -0.29 Beat